GJC2 and lymphedema: The GJC2 variant affects the second transmembrane domain of connexin 47, whereas the OBSCN variant lies in immunoglobulin-like domain 55 of obscurin, a large cytoskeletal signaling protein not previously implicated in lymphedema.